These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15564690)

  • 1. Novel pathophysiological insight and treatment strategies for heart failure--lessons from mice and patients--.
    Tsutsui H
    Circ J; 2004 Dec; 68(12):1095-103. PubMed ID: 15564690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress and mitochondrial DNA damage in heart failure.
    Tsutsui H; Kinugawa S; Matsushima S
    Circ J; 2008; 72 Suppl A():A31-7. PubMed ID: 18772530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial oxidative stress and dysfunction in myocardial remodelling.
    Tsutsui H; Kinugawa S; Matsushima S
    Cardiovasc Res; 2009 Feb; 81(3):449-56. PubMed ID: 18854381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial oxidative stress and heart failure.
    Tsutsui H
    Intern Med; 2006; 45(13):809-13. PubMed ID: 16880705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial oxidative stress, DNA damage, and heart failure.
    Tsutsui H; Ide T; Kinugawa S
    Antioxid Redox Signal; 2006; 8(9-10):1737-44. PubMed ID: 16987026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oxidative stress and heart failure].
    Kinugawa S; Tsutsui H
    Nihon Rinsho; 2006 May; 64(5):848-53. PubMed ID: 16689364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and electrical remodeling as therapeutic targets in heart failure.
    Cutler MJ; Rosenbaum DS; Dunlap ME
    J Electrocardiol; 2007; 40(6 Suppl):S1-7. PubMed ID: 17993305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice.
    Shiomi T; Tsutsui H; Matsusaka H; Murakami K; Hayashidani S; Ikeuchi M; Wen J; Kubota T; Utsumi H; Takeshita A
    Circulation; 2004 Feb; 109(4):544-9. PubMed ID: 14744974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction.
    Most P; Seifert H; Gao E; Funakoshi H; Völkers M; Heierhorst J; Remppis A; Pleger ST; DeGeorge BR; Eckhart AD; Feldman AM; Koch WJ
    Circulation; 2006 Sep; 114(12):1258-68. PubMed ID: 16952982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold M; Abraham WT; Daubert JC;
    Am Heart J; 2006 Feb; 151(2):288-94. PubMed ID: 16442890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Energetic myocardial metabolism and oxidative stress: let's make them our friends in the fight against heart failure.
    Scolletta S; Biagioli B
    Biomed Pharmacother; 2010 Mar; 64(3):203-7. PubMed ID: 19954925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuregulin-1 attenuates mitochondrial dysfunction in a rat model of heart failure.
    Guo YF; Zhang XX; Liu Y; Duan HY; Jie BZ; Wu XS
    Chin Med J (Engl); 2012 Mar; 125(5):807-14. PubMed ID: 22490579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversing chronic remodeling in heart failure.
    Mudd JO; Kass DA
    Expert Rev Cardiovasc Ther; 2007 May; 5(3):585-98. PubMed ID: 17489680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation in HFpEF: Key or circumstantial?
    van Empel V; Brunner-La Rocca HP
    Int J Cardiol; 2015; 189():259-63. PubMed ID: 25897922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of oxidative stress in heart failure].
    Tsutsui H
    Nihon Rinsho; 2003 May; 61(5):756-60. PubMed ID: 12754999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta1 integrins modulate beta-adrenergic receptor-stimulated cardiac myocyte apoptosis and myocardial remodeling.
    Krishnamurthy P; Subramanian V; Singh M; Singh K
    Hypertension; 2007 Apr; 49(4):865-72. PubMed ID: 17283249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocyte iNOS is required for inflammation and pathological remodeling in ischemic heart failure.
    Kingery JR; Hamid T; Lewis RK; Ismahil MA; Bansal SS; Rokosh G; Townes TM; Ildstad ST; Jones SP; Prabhu SD
    Basic Res Cardiol; 2017 Mar; 112(2):19. PubMed ID: 28238121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why should we care about CARE-HF?
    Ellenbogen KA; Wood MA; Klein HU
    J Am Coll Cardiol; 2005 Dec; 46(12):2199-203. PubMed ID: 16360046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NADPH oxidase-dependent oxidative stress in the failing heart: From pathogenic roles to therapeutic approach.
    Octavia Y; Brunner-La Rocca HP; Moens AL
    Free Radic Biol Med; 2012 Jan; 52(2):291-7. PubMed ID: 22080085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol treatment of mice with pressure-overload-induced heart failure improves diastolic function and cardiac energy metabolism.
    Sung MM; Das SK; Levasseur J; Byrne NJ; Fung D; Kim TT; Masson G; Boisvenue J; Soltys CL; Oudit GY; Dyck JR
    Circ Heart Fail; 2015 Jan; 8(1):128-37. PubMed ID: 25394648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.